| Literature DB >> 31480499 |
Abstract
The monarch butterfly in North America has suffered a serious population decline since the mid-1990s. The introduction and widespread use of neonicotinoid insecticides during the same time period has been suggested as a potential driver of this decline but no studies have looked at the impact of these insecticides on adult monarchs. A brief laboratory study assessed the impact of Imidacloprid, the most commonly used neonicotinoid, on western monarch butterfly longevity and oogenesis. Imidacloprid at 23.5 ppb, a field-realistic rate reported from wild nectar and pollen, was fed ad libitum to newly-eclosed monarchs in a sugar-based diet for 22 days. Treated monarchs showed reduced longevity, suffering 78.8% mortality by day 22, compared to 20% in untreated monarchs. Prior to death, butterflies exhibited signs of poisoning including uncoordinated flapping of wings and uncontrolled vibrating of wings and body. Imidacloprid did not reduce egg production. Shortened adult longevity has serious consequences for monarch population development, migration and overwintering. The potential widespread impact of imidacloprid-contaminated crop and wild flower nectar, may be a significant driver of monarch population decline. More research on the impact of neonicotinoid insecticides on the monarch and other butterflies should be viewed as a serious priority.Entities:
Keywords: adult monarch butterfly; imidacloprid; monarch butterfly decline; neonicotinoids; survival
Year: 2019 PMID: 31480499 PMCID: PMC6780620 DOI: 10.3390/insects10090276
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
Forewing lengths (mm) and wet weights (mg) of untreated and imidacloprid-treated monarch butterflies at eclosion and 12 and 22 days post-eclosion. Values in rows with a different letter are significantly different from corresponding value for other sex (p < 0.05). Value with asterisk is significantly different from corresponding value at eclosion (p < 0.05). Numbers in parentheses represent number of individuals examined.
| Forewing (mm) | Male | Female | Wet Weight (mg) | Male | Female |
|---|---|---|---|---|---|
|
| |||||
| Untreated | 46.0 ± 1.1 a (9) | 47.2 ± 2 ± 0.7 a (9) | Untreated | 413.2 ± 18.0 a (9) | 422.8 ± 28.7 a (9) |
| Treated | 46.2 ± 0.5 a (11) | 45.1 ± 0.7 a (11) | Treated | 466.8 ± 28.7 a (11) | 389.0 ± 23.7 b (11) |
|
| |||||
| Untreated | 48.0 ± 0.8 a (4) | 46.8 ± 0.8 a (4) | Untreated | 467.5 ± 15.2 a (4) | 423.5 ± 31.9 a (4) |
| Treated | 46.0 ± 0.4 a (4) | 46.0 ± 1.1 a (4) | Treated | 377.2 ± 21.9 a * (4) | 385.2 ± 59.2 a (4) |
|
| |||||
| Untreated | 46.7 ± 1.2 a (3) | 47.6 ± 1.1 a (5) | Untreated | 360.0 ± 24.2 a * (3) | 457.8 ± 23.9 b (5) |
| Treated | 46.0 ± 2.0 (2) | Treated | 466.5 ± 44.5 (2) |
Figure 1Mortality of caged monarch butterflies fed sugar water alone or sugar water containing 23.5 ppb imidacloprid during three weeks post-eclosion.
Oocyte production in untreated and imidacloprid-treated monarch butterflies at 12 and 22 days post-eclosion. Numbers in parentheses represent number of individuals examined.
| Post-Eclosion Day and Treatment | No. Immature Oocytes | No. Mature Oocytes | No. Total Oocytes | |
|---|---|---|---|---|
| 12 | ||||
| Untreated | 55.8 ± 13.1 | 59.8 ± 6.4 | 115.5 ± 19.3 (4) | |
| Treated | 42.8 ± 4.2 | 59.2 ± 9.8 | 102.0 ± 10.5 (4) | |
| 22 | ||||
| Untreated | 46.0 ± 6.2 | 85.6 ± 7.0 | 131.6 ± 10.2 (5) | |
| Treated | 37.0 ± 9.0 | 68.5 ± 22.5 | 105.5 ± 31.5 (2) |